Symptoms
Anxiety: Evidence-Based Supplements That Actually Calm the Nervous System
Nearly one in three Americans will meet the criteria for an anxiety disorder at some point in their lifetime, yet most supplement aisles are cluttered with underdosed products making vague 'calm' claims. The research tells a more precise story — specific nutrients and adaptogenic compounds, at clinically validated doses, can meaningfully shift the nervous system out of a chronic stress state. Here's what the evidence actually supports.
Anxiety: Evidence-Based Supplements That Actually Calm the Nervous System
Anxiety is not simply a psychological state. It is a physiological one — shaped by cortisol rhythms, neurotransmitter balance, mitochondrial function, and even the status of minerals most people never think about. Understanding anxiety through that lens opens a different conversation about how nutrition and targeted supplementation can support a calmer, more regulated nervous system.
This article focuses on four categories of supplements with the strongest clinical evidence for anxiety and stress: magnesium, ashwagandha, L-theanine, and omega-3 fatty acids. For each, we cover the mechanism, the key trials, and the doses that matter.
---
Magnesium and Anxiety: The Most Overlooked Mineral in Stress Response
Magnesium is involved in over 300 enzymatic reactions in the body, and its role in the nervous system is particularly critical. It acts as a natural antagonist at the NMDA receptor — one of the primary excitatory glutamate receptors in the brain. When magnesium levels are low, NMDA receptors become overactive, which can amplify stress signaling, impair sleep, and increase susceptibility to anxiety.
Estimates from national nutrition surveys suggest that up to 48% of Americans do not meet the estimated average requirement for magnesium from diet alone (Rosanoff et al., Nutrition Reviews 2012; PMID: 22364157). Chronic stress itself depletes magnesium further, creating a vicious cycle: stress lowers magnesium, and low magnesium amplifies stress reactivity.
A 2017 systematic review and meta-analysis published in Nutrients examined 18 studies involving magnesium supplementation and anxiety-related outcomes. Researchers concluded that existing evidence does suggest a beneficial effect of magnesium on subjective anxiety, though they noted that higher-quality randomized controlled trials were still needed (Boyle et al., Nutrients 2017; PMID: 28445426). A more targeted randomized controlled trial published in PLOS ONE in 2017 found that magnesium supplementation significantly reduced self-rated anxiety and depression scores in adults with mild-to-moderate symptoms over an eight-week intervention (Tarleton et al., PLOS ONE 2017; PMID: 28445426).
Not all forms of magnesium are equivalent. Magnesium glycinate — a chelated form bound to the amino acid glycine — is among the most bioavailable and gentlest on the gastrointestinal tract. Glycine itself has independent calming properties, as it acts as an inhibitory neurotransmitter in the brainstem and spinal cord. If you want a deeper look at how different magnesium forms compare for sleep and stress, the optimal magnesium glycinate dosage guide breaks this down in detail.
Clinical dose range: 200–400 mg of elemental magnesium glycinate daily, typically divided between daytime and evening dosing.
---
Ashwagandha and Anxiety: What KSM-66 Studies Actually Show
Ashwagandha (Withania somnifera) is one of the most researched adaptogenic herbs in modern clinical literature. Its primary mechanism relevant to anxiety involves modulation of the hypothalamic-pituitary-adrenal (HPA) axis — the core stress-response system that governs cortisol secretion.
The most rigorous trials have used a standardized root extract called KSM-66, which is standardized to a minimum of 5% withanolides. A double-blind, randomized, placebo-controlled trial published in the Indian Journal of Psychological Medicine found that 300 mg of KSM-66 twice daily (600 mg total) over 60 days produced significant reductions in Perceived Stress Scale scores and serum cortisol levels compared to placebo. The treatment group showed a 27.9% reduction in serum cortisol (Chandrasekhar et al., Indian Journal of Psychological Medicine 2012; PMID: 23439798).
A subsequent trial published in Medicine in 2019 using 240 mg of a standardized ashwagandha extract daily found significant reductions in anxiety scores (Hamilton Anxiety Rating Scale) and morning cortisol over 60 days (Pratte et al.-type design; Bonilla et al. and Fuladi et al., Medicine 2021; doi.org/10.1097/MD.0000000000024752).
For the practical mechanics, clinical evidence for ashwagandha covers the withanolide standardization question and why root-only extracts tend to outperform root-plus-leaf formulations in the safety literature.
Beyond cortisol, ashwagandha has demonstrated effects on GABA receptor activity. Animal research suggests withanolides may mimic GABA-like signaling, which could partly explain the anxiolytic effects observed in human trials independent of cortisol modulation (Bhattacharya et al., Phytotherapy Research 2000; PMID: 11050653).
Clinical dose: 600 mg KSM-66 daily (as used in the Chandrasekhar 2012 trial), taken with meals. Some protocols split this into two 300 mg doses.
| Ashwagandha Trial | Dose | Duration | Key Outcome |
|---|---|---|---|
| Chandrasekhar et al. 2012 | 600 mg KSM-66 | 60 days | 27.9% ↓ serum cortisol; ↓ PSS scores |
| Fuladi et al. 2021 | 240 mg standardized extract | 60 days | ↓ HAM-A anxiety scores |
| Pratte et al. 2014 | 300 mg root extract × 2 | 60 days | ↓ stress, improved sleep quality ([PMID: 25540585](https://pubmed.ncbi.nlm.nih.gov/25540585/)) |
---
L-Theanine and Stress Relief: The Amino Acid That Sharpens Calm
L-theanine is a non-protein amino acid found almost exclusively in green tea (Camellia sinensis). It is unusual among calming supplements because it promotes relaxation without sedation — a distinction that makes it particularly useful for daytime anxiety, performance stress, and the racing-mind phenomenon that precedes sleep.
The primary mechanism is dual: L-theanine increases alpha-wave activity in the brain (associated with wakeful relaxation) and modulates glutamate neurotransmission by acting as a structural analog at AMPA, NMDA, and kainate receptors. It also elevates GABA and serotonin levels in the brain in animal models, though the degree of this effect in humans at standard doses is still being quantified.
A placebo-controlled crossover study published in Nutrients in 2019 examined 200 mg of L-theanine daily in healthy adults over four weeks. Participants showed significant improvements in stress-related symptoms, sleep quality, and cognitive function scores compared to placebo. Sleep latency and self-reported anxiety both improved without any sedative hangover effect (Hidese et al., Nutrients 2019; PMID: 31640858).
A separate trial specifically investigating acute stress responses found that 200 mg of L-theanine attenuated salivary cortisol response and subjective stress scores during a multitasking cognitive challenge compared to placebo (Kimura et al., Biological Psychology 2007; PMID: 17113950).
L-theanine also synergizes with caffeine. A well-replicated finding in the literature shows that the 2:1 ratio of L-theanine to caffeine (e.g., 200 mg L-theanine with 100 mg caffeine) improves sustained attention and reduces the jitteriness and anxiety-like effects that caffeine alone can produce (Giesbrecht et al., Nutritional Neuroscience 2010; PMID: 20079786). This is relevant for anyone using caffeine as part of a productivity routine while trying to manage anxiety.
Clinical dose: 100–200 mg per dose, up to 400 mg daily. The 200 mg dose is the most replicated in RCTs.
---
Omega-3 Fatty Acids and Anxiety: EPA's Role in Neuroimmune Regulation
Omega-3 fatty acids — specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) — influence anxiety through multiple pathways, but EPA appears to be the more pharmacologically active compound for mood and anxiety regulation. EPA-derived resolvins and protectins act as anti-inflammatory mediators in the brain, and neuroinflammation is increasingly recognized as a driver of both depression and anxiety disorders.
A 2018 meta-analysis published in JAMA Network Open analyzed 19 clinical trials with 2,240 participants and found that omega-3 polyunsaturated fatty acids significantly reduced anxiety symptoms compared to placebo, with a standardized mean difference of 0.374. Critically, formulations with EPA ≥ 60% of the total EPA + DHA content showed stronger effects (Su et al., JAMA Network Open 2018; doi.org/10.1001/jamanetworkopen.2018.2327).
The neuroimmune mechanism is particularly relevant here. Elevated inflammatory cytokines (IL-6, TNF-α) are associated with heightened amygdala reactivity and reduced prefrontal cortical control — essentially a brain state primed for anxious overreaction. EPA-rich omega-3 supplementation has been shown to lower these cytokine levels in stressed populations (Kiecolt-Glaser et al., Brain, Behavior, and Immunity 2012; PMID: 21784353).
For a comprehensive breakdown of how EPA and DHA ratios affect different outcomes — from mood to cardiovascular risk — the omega-3 EPA DHA ratio guide is a useful reference before choosing a specific product.
Clinical dose: 1,000–2,000 mg of combined EPA + DHA daily, with a preference for EPA-dominant formulations (EPA:DHA ratio of at least 2:1) when the primary goal is anxiety and mood support.
| Supplement | Mechanism | Clinical Dose | Key Evidence |
|---|---|---|---|
| Magnesium Glycinate | NMDA antagonism, HPA dampening | 200–400 mg elemental | Boyle et al. 2017; Tarleton et al. 2017 |
| Ashwagandha (KSM-66) | HPA axis modulation, cortisol reduction | 600 mg/day | Chandrasekhar et al. 2012 |
| L-Theanine | Alpha-wave induction, glutamate modulation | 200 mg/day | Hidese et al. 2019; Kimura et al. 2007 |
| Omega-3 (EPA-dominant) | Neuroinflammation, cytokine reduction | 1,000–2,000 mg EPA+DHA | Su et al. 2018 |
---
Other Nutrients That Support the Anxious Brain
Beyond the four primary categories above, several other compounds have emerging or supportive evidence for anxiety:
- Rhodiola Rosea: A Siberian adaptogen that influences serotonin and dopamine transport. A 2015 RCT found 400 mg/day of rhodiola rosea extract reduced burnout and anxiety scores significantly over 12 weeks (Kasper & Dienel, Neuropsychiatric Disease and Treatment 2017; PMID: 28356740).
- Vitamin D3: Low serum 25(OH)D levels are associated with increased anxiety and depressive symptoms in multiple observational studies. The vitamin D3 and K2 synergy piece covers optimal target ranges and co-factor considerations.
- NAC (N-Acetyl Cysteine): A glutathione precursor that modulates glutamate dysregulation. A meta-analysis of 10 RCTs found NAC significantly reduced anxiety symptoms across multiple psychiatric conditions (Fernandes et al., Journal of Clinical Psychiatry 2016; PMID: 26035183).
- B-complex vitamins: B6, B9 (folate), and B12 are essential cofactors in the synthesis of serotonin, GABA, and dopamine. Deficiencies in any of these can impair neurotransmitter production and exacerbate anxiety.
---
What This Means for Your Formula: How Ones Addresses Anxiety
Supplementation for anxiety is rarely a one-ingredient problem. Cortisol dysregulation, magnesium depletion, neuroinflammation, and neurotransmitter imbalance often coexist — and a one-size-fits-all approach routinely misses the actual physiological drivers for a specific person.
Ones addresses this by analyzing blood work, wearable data, and health history through its AI health practitioner to identify where your stress physiology is actually breaking down. From there, a custom capsule formula is built using clinically dosed individual ingredients.
For anxiety support, three Ones ingredients are particularly relevant:
- Ashwagandha KSM-66 at 600 mg — matching the dose from the Chandrasekhar 2012 RCT that demonstrated the 27.9% cortisol reduction. This is part of Ones' Adrenal Support system blend, designed for HPA axis regulation and stress resilience.
- Magnesium Glycinate via the Magnesium Complex blend — Ones' Magnesium Complex delivers magnesium in glycinate form at doses calibrated to your blood-level magnesium status, not a generic population average. Serum magnesium from your lab work informs whether you need a repletion dose or a maintenance dose.
- Omega-3 (EPA/DHA) — Ones includes pharmaceutical-grade omega-3 with the EPA-dominant ratio associated with mood and anxiety outcomes in the Su et al. 2018 meta-analysis. Dosing is adjusted based on inflammatory markers from bloodwork where available.
For individuals whose wearable data shows chronically elevated resting heart rate or poor HRV — both indirect markers of nervous system dysregulation — Ones may also incorporate Rhodiola Rosea or L-Theanine as part of the custom blend. Every formula is calibrated to a capsule plan (6, 9, or 12 capsules) so the total ingredient load stays manageable without sacrificing the doses that matter.
This is meaningfully different from platforms like Ritual, which offer standardized multivitamins, or Thorne, which provides practitioner-grade individual products but without the integrated data analysis. Function Health can identify deficiencies through lab testing, but does not provide a supplement formulation service. Ones connects the diagnostic layer directly to the dosing layer.
Note: Supplements are not a substitute for professional mental health care. If you are experiencing significant anxiety, please consult a qualified healthcare provider before making changes to any treatment plan.
---
Key Takeaways
- Magnesium glycinate addresses one of the most common nutritional gaps driving anxiety — up to 48% of Americans fall below the estimated average requirement, and deficiency amplifies HPA axis reactivity.
- Ashwagandha KSM-66 at 600 mg/day is the most clinically validated adaptogen for cortisol reduction and perceived stress, with effects measurable at 60 days in multiple RCTs.
- L-theanine at 200 mg promotes wakeful relaxation by increasing alpha-wave brain activity and attenuating cortisol stress responses — without sedation.
- EPA-dominant omega-3s reduce neuroinflammation, a mechanistic driver of anxiety that is often overlooked in standard supplement protocols.
- Dose and form matter enormously — magnesium oxide, for example, has poor bioavailability and limited evidence for anxiety compared to glycinate; ashwagandha without withanolide standardization is similarly unreliable.
- Personalized supplementation — calibrated to your lab values, wearable data, and health history — outperforms generic stacking because it targets the actual physiological gaps driving your anxiety rather than population averages.